Hindustan Unilever Limited

Diversified FMCG

Annual Returns

Cumulative Returns and Drawdowns

Fundamentals

Ownership

Margined

AI Summary

asof: 2025-12-03

Analysis of Hindustan Unilever Limited (HINDUNILVR) – Headwinds, Tailwinds, Growth Prospects, and Key Risks

Overall Snapshot (Based on SQ’25 and H1 FY’26 Results, Oct 2025): - Financials: SQ’25 USG +2% (UVG flat), H1 USG +3% (UVG +5%). EBITDA margin 23.2% (-90 bps YoY SQ’25; -110 bps H1). PAT +4% SQ’25 (+5% H1); PAT bei -4%. Sales ₹16,061 cr SQ’25; interim dividend ₹19/share. - Strategic Context: Transitory GST disruptions and monsoon impacted Q2, but management eyes H2 recovery. Focus on volume-led growth via premiumisation, innovations, and portfolio transformation (Ice Cream demerger via KWIL scheme progressing). New CEO Priya Nair approved; board strengthened with Bobby Parikh (ID). - Market Position: Resilient with >85% #1 brands, 19 brands >$1bn turnover, 9mn retailer reach, 80bn annual consumer interactions.

Tailwinds (Positive Catalysts)

GST Reforms: New-age changes (1,200+ SKUs repriced) to boost disposable income, sentiment, and premiumisation; full benefits passed to consumers for demand uplift.
Category Strengths:
- Home Care: Mid-singles UVG (liquids double-digit).
- Beauty & Wellbeing: +5% USG (Skin Care high-singles; Health & Wellbeing triple-digit via OZiva).
- Foods: Beverages double-digit (Tea high-singles, Coffee robust).
Strategic Investments: A&P +80 bps YoY (10.3%); launches (Vaseline Cloud Soft, Pond’s Hydra Miracle, Comfort Perfume Deluxe, Horlicks PRO Fitness, BRU Gold).
Leadership & Governance: Priya Nair (30+ yrs Unilever exp., ex-Beauty & Wellbeing President) as CEO (99.88% shareholder approval). Bobby Parikh (ex-EY CEO, Infosys/ Biocon ID) as ID/ Risk Chair.
Portfolio Power: Deep distribution moat; AI efficiencies; consumer segmentation (Power Spenders/Premiumisers/Democratisers); “Fewer, bigger bets” in high-growth spaces.
KWIL Scheme: Ice Cream separation advancing (office shift, board reconstitution); unlocks value per SEBI observations.

Headwinds (Challenges)

GST Transition: Temporary disruptions (trade de-stocking, delayed buying, pricing shifts) across categories (Hair Care decline, Personal Care flat, Packaged Foods muted, Ice Cream YoY drop).
External Factors: Prolonged/intense monsoon hit Ice Cream/demand; stable but weak FMCG volume trends (rural/urban flat MAT Sep’25).
Margin Pressure: EBITDA dip from investments; Gross Margin -10 bps; commodity divergence.
Category Weakness: UVG declines (Personal Care high-singles; Lifestyle Nutrition turnover drop post-pricing); Oral Care marginal decline.
Macro: Subdued consumption; rural recovery pending.

Growth Prospects

Near-Term (H2 FY’26): Normal trading post-Oct; low-single digit pricing (if commodities stable); H2 > H1. EBITDA margins steady ex-Ice Cream.
Mid/Long-Term:
- Volume-Led Acceleration: Radical segmentation, modern core brands (e.g., Surf Excel, Lux refresh), premiumisation (Future Core/Market Makers).
- High-Growth Bets: Health & Wellbeing (triple-digit sustained); ecom/Channels of Future (double-digit); digital marketing/sales (AI-powered).
- Ice Cream Unlock: KWIL scheme (post-approval) to streamline FMCG focus.
- Robust Moats: #1 employer; innovation pipeline; 3-yr share plans tied to growth/TSR/sustainability.
Outlook: Competitive UVG trajectory; supportive macros (GST tailwinds).

Category	SQ’25 USG/UVG	Key Driver
Home Care	Flat / Mid-singles	Liquids premiumisation
Beauty & Wellbeing	+5% / Flat	Skin/Health growth
Personal Care	Flat / High-singles decline	GST hit
Foods	+3% / Low-singles	Beverages offset Ice Cream

Key Risks

Risk Category	Description	Mitigation
Execution/Operational	GST lingering into Nov; transformation delays (e.g., premiumisation, sales machine).	Agile pricing; frontline focus.
Macro/External	Commodity volatility; weak rural demand; monsoons/climate.	Hedging; distribution depth.
Regulatory/Corporate	KWIL scheme delays (NCLT/SEBI approvals); tax/forex fluctuations.	Continuous disclosures.
Competitive	Intense pricing wars; market share erosion in weak categories.	#1 positions; innovations.
Financial	Margin sustained pressure from A&P/capex; PAT bei dip.	Cost efficiencies (AI).
Leadership/Other	New CEO integration; forex/tax on global comp (Priya Nair’s package ~₹27cr target).	Proven Unilever track record.

Balanced View: HUL’s resilient model shines amid headwinds (GST/monsoon), with strong tailwinds from reforms/leadership/portfolio. Growth hinges on H2 recovery and execution of “volume-led” priorities—positioned for mid-teens EPS growth long-term if macros aid. Recommendation: Hold/Buy on dips; monitor Q3 results (Jan 2026) for GST normalcy. (Analysis based solely on provided docs; no external data.)

HINDUNILVR

Equity Metrics

May 8, 2026